Benzinga | Jun 2, 2021 08:38AM EDT

BTIG Maintains Buy on Abbott Laboratories, Lowers Price Target to $120

BTIG maintains Abbott Laboratories (NYSE:ABT) with a Buy and lowers the price target from $140 to $120.